@ctruncale66@thehealthb0t I too did the same thing. Thank god bc of me explaining to them about the truth of it all. They never took the death jab. But unfortunately lost my heathy dad because he died from the jab and booster shots. 4 yrs ago.
@thehealthb0t That whole thing was a test drill. I knew about it from the start. I never fell for it. Being in the healthcare industry. Those masks ( filled with germs) worn every day, caused a lot of ppl to develop lung damage. I never got the jab nor, wore a mask.
@Avabelly__ Who care’s. Don’t look at him. At least he’s taking care of HIS property. I bet if he was a young hot guy doing it. You would love watching him. 😂
Several states have confirmed they will be using mRNA vaccines on their livestock.
Food that has been genetically edited can now be marketed as non-GMO.
BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal
84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.
Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.
The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.
A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.
Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.
At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)
Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.
Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.
This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.
With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.
In the meantime, many cancer patients are exercising their right to try.
@twc_health@McCulloughFund@IIAR_Journals@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly@FosterCoulson
Renowned Oncologist Angus Dalgleish: "The mRNA vaccines are all completely CONTAMINATED...they are all FULL of SV40."
"SV40 makes tumors GROW...& we're putting this into HUMANS!"
"Pfizer & Moderna are pure evil and MUST be held to account."